All filters
Slidesets
Abstract: Prevalence of neuropsychiatric conditions among HIV positive compared to HIV negative commercially insured individuals in 2017 NAFLD with dyslipidemia (#5) | Joshua Cohen, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in a rapid initiation model of care for HIV-1 infection: Week 24 interim analysis of the DIAMOND study (#6) | Keith Dunn, PharmD, BCPS, AAHIVE
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael Aboud
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Hispanic/Latino longitudinal cohort of HIV-seropositive women and neurological complications | Loyda Melendez, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Rhesus macaque model of SIV/SHIV-Zika co-infection (#9) | Siddappa Byrareddy
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Understanding barriers to HIV cure | Robert Siliciano, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Gertrude Elion Distinguished Lecturer Award Lecture: Innovation with an Impact: Development of HIV and TB drugs | Paul Stoffels, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Potential for HIV cure by stem cell transplantation (IciStem) | Monique Nijhuis, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCs (#3) | Nicolas Margot
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Abstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc Steens
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhD
Presented at:
HIV DART and Emerging Viruses 2018
Slidesets
Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhD
Presented at:
RespiDART 2018
Slidesets
Abstract: SB 9200 is a novel broad-spectrum antiviral agent effective against both RSV and Flu (#101) | Diane Schmidt
Presented at:
RespiDART 2018
Slidesets
Abstract: Structure-based prediction of influenza resistance mutations (#102) | Bryan Cox
Presented at:
RespiDART 2018
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018